<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2739-0063</journal-id>
<journal-title><![CDATA[Revista InveCom]]></journal-title>
<abbrev-journal-title><![CDATA[Revista InveCom]]></abbrev-journal-title>
<issn>2739-0063</issn>
<publisher>
<publisher-name><![CDATA[Asociación Investigadores Venezolanos de la Comunicación]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2739-00632026000303119</article-id>
<article-id pub-id-type="doi">10.5281/zenodo.17902321</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Efectos del uso prolongado de esteroides anabólicos sobre el riesgo de cáncer de próstata: revisión sistemática]]></article-title>
<article-title xml:lang="en"><![CDATA[Effects of long-term anabolic steroid use on the risk of prostate cancer: systematic review]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández-Sánchez]]></surname>
<given-names><![CDATA[Giovanna]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramírez-Oyola]]></surname>
<given-names><![CDATA[Luigi Omar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez-Urruchi]]></surname>
<given-names><![CDATA[Ana Bridgette]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vela-Ruíz]]></surname>
<given-names><![CDATA[José Manuel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Privada San Juan Bautista  ]]></institution>
<addr-line><![CDATA[Lima ]]></addr-line>
<country>Peru</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Privada San Juan Bautista  ]]></institution>
<addr-line><![CDATA[Lima ]]></addr-line>
<country>Peru</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Privada San Juan Bautista  ]]></institution>
<addr-line><![CDATA[Lima ]]></addr-line>
<country>Peru</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad Ricardo Palma  ]]></institution>
<addr-line><![CDATA[Lima ]]></addr-line>
<country>Peru</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2026</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2026</year>
</pub-date>
<volume>6</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_arttext&amp;pid=S2739-00632026000303119&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_abstract&amp;pid=S2739-00632026000303119&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_pdf&amp;pid=S2739-00632026000303119&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen El uso de esteroides anabólicos derivados de la testosterona, empleados para mejorar el rendimiento y el desarrollo muscular, está asociado con un mayor riesgo de cáncer, especialmente cuando se utilizan sin una razón médica. El estudio tuvo como objetivo analizar la literatura en referencia al uso prolongado de esteroides anabólicos sobre el riesgo de cáncer de próstata. Para evaluar la literatura existente sobre el tema, se llevó a cabo una revisión de alcance utilizando el modelo PRISMA y el método propuesto por Arksey y O'Malley. De los 49 documentos seleccionados para el análisis, el 22.4% eran estudios de caso y el 32.7% eran de carácter cualitativo. PubMed fue la fuente seleccionada para la recopilación de datos (57.1%). Estados Unidos representó el 49% de todas las publicaciones, siendo el inglés el idioma preferido para la mayoría de ellas (73.5%). Según la investigación actual, el uso de esteroides no parece aumentar sustancialmente el riesgo de cáncer de próstata a corto o medio plazo. Sin embargo, es evidente que los esteroides tienen efectos negativos en la salud mental y en muchos sistemas del cuerpo. En conclusión, aunque los esteroides tienen efectos negativos graves y posiblemente duraderos en la salud, no hay pruebas de que aumenten la incidencia de cáncer de próstata. En consecuencia, para reducir los peligros del uso de esteroides, es importante abogar por una investigación cuantitativa más exhaustiva con seguimiento a largo plazo y establecer medidas de educación, monitoreo médico y regulación.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The use of testosterone-derived anabolic steroids, used to improve performance and muscle development, is associated with an increased risk of cancer, especially when used without medical reason. The study aimed to analyze the literature on the prolonged use of anabolic steroids and the risk of prostate cancer. To evaluate the existing literature on the subject, a scoping review was conducted using the PRISMA model and the method proposed by Arksey and O'Malley. Of the 49 documents selected for analysis, 22.4% were case studies and 32.7% were qualitative in nature. PubMed was the source selected for data collection (57.1%). The United States accounted for 49% of all publications, with English being the preferred language for most of them (73.5%). According to current research, steroid use does not appear to substantially increase the risk of prostate cancer in the short or medium term. However, it is clear that steroids have negative effects on mental health and many body systems. In conclusion, although steroids have serious and possibly long-lasting negative effects on health, there is no evidence that they increase the incidence of prostate cancer. Consequently, to reduce the dangers of steroid use, it is important to advocate for more comprehensive quantitative research with long-term follow-up and to establish measures for education, medical monitoring, and regulation.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[esteroides anabólicos]]></kwd>
<kwd lng="es"><![CDATA[cáncer de próstata]]></kwd>
<kwd lng="es"><![CDATA[riesgo a la salud]]></kwd>
<kwd lng="en"><![CDATA[anabolic steroids]]></kwd>
<kwd lng="en"><![CDATA[prostate cancer]]></kwd>
<kwd lng="en"><![CDATA[health risk]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alfi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Sidharta]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rizky]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Suriani]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Yulianto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The long-term urological consequences of anabolic steroid abuse: A narrative review]]></article-title>
<source><![CDATA[Journal of Afiyah Health Research]]></source>
<year>2024</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>463-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arksey]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Malley]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scoping studies: Towards a methodological framework]]></article-title>
<source><![CDATA[International Journal of Social Research Methodology]]></source>
<year>2005</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-32</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ayumi]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Mendonça]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Vidal]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Leal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impactos sistêmicos do uso de esteroides anabolizantes androgênicos: riscos e prevenção]]></article-title>
<source><![CDATA[Brazilian Journal of Health Review]]></source>
<year>2024</year>
<volume>7</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berrehail]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Boibessot]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Gris]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Joncas]]></surname>
<given-names><![CDATA[F. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Gaignier]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Guillemette]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Lacombe]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Fradet]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Toren]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sex steroid modulation of macrophages within the prostate tumor microenvironment]]></article-title>
<source><![CDATA[American Journal of Clinical and Experimental Urology]]></source>
<year>2022</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>98-110</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boye]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Acheampong]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Brah]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Therapeutic prospects of sex hormone receptor signaling in hormone-responsive cancers]]></article-title>
<source><![CDATA[Biomedicine &amp; Pharmacotherapy]]></source>
<year>2024</year>
<volume>180</volume>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bray]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Laversanne]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Sung]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Ferlay]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Siegel]]></surname>
<given-names><![CDATA[R. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Soerjomataram]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Jemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries]]></article-title>
<source><![CDATA[CA: A Cancer Journal for Clinicians]]></source>
<year>2024</year>
<volume>74</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>229-63</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Iniciativa basada en la evidencia para regular la prescripción y venta de esteroides anabólicos androgénicos]]></article-title>
<source><![CDATA[UVserva]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eisermann]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Broderick]]></surname>
<given-names><![CDATA[C. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Bazarov]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Moazam]]></surname>
<given-names><![CDATA[M. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Fraizer]]></surname>
<given-names><![CDATA[G. C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site]]></article-title>
<source><![CDATA[Molecular Cancer]]></source>
<year>2013</year>
<volume>12</volume>
<page-range>7</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Esposito]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Salerno]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Calvano]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Agliozzo]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Ficarra]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Sessa]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Favilla]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Cimino]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Pomara]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of anabolic androgenic steroids on male sexual and reproductive function: A systematic review]]></article-title>
<source><![CDATA[Panminerva Medica]]></source>
<year>2023</year>
<volume>65</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>43-50</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gestsdottir]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Kristjansdottir]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Sigurdsson]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Sigfusdottir]]></surname>
<given-names><![CDATA[I. D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence, mental health and substance use of anabolic steroid users: A population-based study on young individuals]]></article-title>
<source><![CDATA[Scandinavian Journal of Public Health]]></source>
<year>2021</year>
<volume>49</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>555-62</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heerfordt]]></surname>
<given-names><![CDATA[I. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Windfeld-Mathiasen]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Dalhoff]]></surname>
<given-names><![CDATA[K. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Trærup Andersen]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Horwitz]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Excessive androgen exposure and risk of malignancies: A cohort study]]></article-title>
<source><![CDATA[Andrology]]></source>
<year>2025</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>296-301</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández Fernández]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Salim]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz González]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectos secundarios derivados del consumo de esteroides anabólicos en el deportista]]></article-title>
<source><![CDATA[Revista Iberoamericana de Ciencias de la Actividad Física y el Deporte]]></source>
<year>2017</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26-46</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoseini]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Hoseini]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exploring the prevalence of anabolic steroid use among men and women resistance training practitioners after the COVID-19 pandemic]]></article-title>
<source><![CDATA[BMC Public Health]]></source>
<year>2024</year>
<volume>24</volume>
<numero>798</numero>
<issue>798</issue>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ielasi]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Fulco]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Reggidori]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Domenicali]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Foschi]]></surname>
<given-names><![CDATA[F. G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anabolic androgenic steroids and hepatocellular adenoma and carcinoma: Molecular mechanisms and clinical implications]]></article-title>
<source><![CDATA[Gastroenterology Insights]]></source>
<year>2024</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>599-613</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leite]]></surname>
<given-names><![CDATA[M. J. Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Pizzocaro]]></surname>
<given-names><![CDATA[A. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Faria]]></surname>
<given-names><![CDATA[G. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Cunha]]></surname>
<given-names><![CDATA[T. da S.]]></given-names>
</name>
<name>
<surname><![CDATA[Nakashima]]></surname>
<given-names><![CDATA[V. M. I.]]></given-names>
</name>
<name>
<surname><![CDATA[Mutran]]></surname>
<given-names><![CDATA[T. M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Rosa]]></surname>
<given-names><![CDATA[M. L. G. G.]]></given-names>
</name>
<name>
<surname><![CDATA[Martins Junior]]></surname>
<given-names><![CDATA[R. A. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Júdice]]></surname>
<given-names><![CDATA[W. A. de S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[O uso de esteroides anabolizantes em esportistas]]></article-title>
<source><![CDATA[Revista Eletrônica Acervo Saúde]]></source>
<year>2024</year>
<volume>24</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levac]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Colquhoun]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Brien]]></surname>
<given-names><![CDATA[K. K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scoping studies: Advancing the methodology]]></article-title>
<source><![CDATA[Implementation Science]]></source>
<year>2010</year>
<volume>5</volume>
<page-range>69</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehralivand]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Puhr]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Claessens]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Van de Merbel]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Dubrovska]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Jenster]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Bernemann]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Sommer]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Erb]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[New advances of the androgen receptor in prostate cancer]]></article-title>
<source><![CDATA[Journal of Translational Medicine]]></source>
<year>2024</year>
<volume>22</volume>
<page-range>71</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mingxing]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Yanfei]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adverse effects of anabolic androgenic steroid abuse in athletes and physically active individuals: A systematic review and meta-analysis]]></article-title>
<source><![CDATA[Substance Use &amp; Misuse]]></source>
<year>2025</year>
<volume>60</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>873-87</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nunes]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Lopes]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Silvia]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Lopes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[O risco do uso indiscriminado de esteroides anabolizantes para performance corporal]]></article-title>
<source><![CDATA[Brazilian Journal of Health Review]]></source>
<year>2024</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Dietary intake of advanced glycation endproducts and cancer risk at more than 20 anatomical sites: A multinational cohort study]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Page]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[McKenzie]]></surname>
<given-names><![CDATA[J. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Bossuyt]]></surname>
<given-names><![CDATA[P. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Boutron]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffmann]]></surname>
<given-names><![CDATA[T. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Mulrow]]></surname>
<given-names><![CDATA[C. D.]]></given-names>
</name>
<name>
<surname><![CDATA[&#8230; Moher]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La declaración PRISMA 2020: Una guía actualizada para informar revisiones sistemáticas]]></article-title>
<source><![CDATA[Systematic Reviews]]></source>
<year>2021</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qasim Ali]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Alshammary]]></surname>
<given-names><![CDATA[R. A. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ghazi Alshammary]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Jouda]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A hormonal side effect of anabolic steroids among a sample of Baghdad male bodybuilders]]></article-title>
<source><![CDATA[Steroids]]></source>
<year>2024</year>
<volume>209</volume>
<page-range>109465</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ríos González]]></surname>
<given-names><![CDATA[J. S.]]></given-names>
</name>
<name>
<surname><![CDATA[González Fajardo]]></surname>
<given-names><![CDATA[K. D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atajos peligrosos para un físico ideal: Esteroides anabólicos y sus riesgos]]></article-title>
<source><![CDATA[Pregones de Ciencia]]></source>
<year>2025</year>
<volume>1</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>50-5</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Alfaro]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez Castillo]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Salas Boza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Esteroides anabólicos: repercusiones médicas del uso indiscriminado con fines en la mejora del rendimiento atlético]]></article-title>
<source><![CDATA[Revista Médica Sinergia]]></source>
<year>2020</year>
<volume>5</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salerno]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Cascio]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Bertozzi]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Sessa]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Messina]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Monda]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Cipolloni]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Biondi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Daniele]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pomara]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: A literature review]]></article-title>
<source><![CDATA[Oncotarget]]></source>
<year>2018</year>
<volume>9</volume>
<numero>27</numero>
<issue>27</issue>
<page-range>19415-26</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Skrzypiec-Spring]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rozmus]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Abu Faraj]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Brawa&#324;ska-Ma&#347;luch]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Kujawa]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Szel&#261;g]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abuse of anabolic-androgenic steroids as a social phenomenon and medical problem: Its potential negative impact on reproductive health based on 50 years of case report analysis]]></article-title>
<source><![CDATA[Journal of Clinical Medicine]]></source>
<year>2024</year>
<volume>13</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>5892</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sorrentino]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[D&#8217;Angiolo]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Gentile]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Giovannelli]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Perillo]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Migliaccio]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Castoria]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Di Donato]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The androgen regulation of matrix metalloproteases in prostate cancer and its related tumor microenvironment]]></article-title>
<source><![CDATA[Endocrines]]></source>
<year>2023</year>
<volume>4</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>350-65</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tauchen]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Jurá&#353;ek]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Huml]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Rimpelová]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicinal use of testosterone and related steroids revisited]]></article-title>
<source><![CDATA[Molecules]]></source>
<year>2021</year>
<volume>26</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1032</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Urios López]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectos adversos asociados al uso de anabolizantes en deportistas: Revisión sistemática]]></article-title>
<source><![CDATA[Ars Pharmaceutica]]></source>
<year>2018</year>
<volume>59</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>45-51</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wiren]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Stocks]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Rinaldi]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Hallmans]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Bergh]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Stenman]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Kaaks]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Stattin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Androgens and prostate cancer risk: A prospective study]]></article-title>
<source><![CDATA[The Prostate]]></source>
<year>2007</year>
<volume>67</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1230-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
